Baird Financial Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $33.8M | Sell |
|
|||||
|
2025
Q2 | $55.7M | Sell |
|
|||||
|
2025
Q1 | $46.9M | Buy |
|
|||||
|
2024
Q4 | $31.3M | Sell |
|
|||||
|
2024
Q3 | $31.1M | Sell |
|
|||||
|
2024
Q2 | $104M | Sell |
|
|||||
|
2024
Q1 | $135M | Sell |
|
|||||
|
2023
Q4 | $123M | Buy |
|
|||||
|
2023
Q3 | $85.1M | Buy |
|
|||||
|
2023
Q2 | $103M | Buy |
|
|||||
|
2023
Q1 | $77.7M | Buy |
|
|||||
|
2022
Q4 | $75.3M | Sell |
|
|||||
|
2022
Q3 | $54.9M | Buy |
|
|||||
|
2022
Q2 | $47.9M | Buy |
|
|||||
|
2022
Q1 | $81M | Buy |
|
|||||
|
2021
Q4 | $82.9M | Sell |
|
|||||
|
2021
Q3 | $115M | Sell |
|
|||||
|
2021
Q2 | $90.4M | Buy |
|
|||||
|
2021
Q1 | $52.1M | Sell |
|
|||||
|
2020
Q4 | $57.1M | Sell |
|
|||||
|
2020
Q3 | $66.5M | Sell |
|
|||||
|
2020
Q2 | $67.6M | Sell |
|
|||||
|
2020
Q1 | $71.5M | Buy |
|
|||||
|
2019
Q4 | $47.4M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $1.76M | Sell |
|
|||||
|
2016
Q1 | $1.52M | Sell |
|
|||||
|
2015
Q4 | $2.52M | Sell |
|
|||||
|
2015
Q3 | $2.98M | Buy |
|
|||||
|
2015
Q2 | $2.47M | Buy |
|